ClinicalTrials.Veeva

Menu

Immersive Sensory Projections for Hospitalized Patients (IHP)

G

GCS Ramsay Santé pour l'Enseignement et la Recherche

Status

Enrolling

Conditions

Hospitalism

Treatments

Procedure: Hospitalization in intensive care or continuing care unit

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT06577870
2024-A01322-45

Details and patient eligibility

About

The purpose of this study is to assess the impact of adding three sensory elements (visual, auditory, olfactory) on reducing discomfort in patients hospitalized in the intensive care unit/continuing care unit.

Full description

The IHP trial is multicenter, interventional, prospective, randomized, controlled, open-label study.

The study population consists of adult patients hospitalized in an intensive care or continuing care unit for medical or surgical reasons, conscious or unconscious under mechanical ventilation.

All patients participating in the study will be managed according to usual practices in intensive care and continuing care units. All patients and their relatives will be monitored and supported by the medical team as in normal practice.

The study will be offered to the patient or a close relative/trusted person on admission to hospital.

Enrollment

208 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age ≥ 18 years ;
  • Patient hospitalized in intensive care or continuing care unit for an estimated minimum of 48 hours;
  • Patient hospitalized for a medical indication (including in the pre-surgical phase) or in the post-surgical phase;
  • Patient or support person who speaks and understands French, has understood the research procedures and is able to complete the questionnaires;
  • For women of childbearing age (non-menopausal), even for those on contraception: negative pregnancy test (urinary); If positive: completed by a biological test;
  • Patient or trusted support person having been informed and having signed an informed consent form to participate in the study.

Exclusion criteria

  • Deaf or blind patient;
  • Asthmatic patient with background treatment;
  • Epileptic patient or known history of convulsion;
  • Known allergy or intolerance to essential oils or to a component of essential oils;
  • Patient transferred from another intensive care unit;
  • Protected patient (under legal protection, or deprived of liberty by judicial or administrative decision);
  • Breast-feeding or pregnant women;
  • Patient or support person unable to understand information relating to the study (linguistic, psychological, cognitive, etc.);
  • Unconscious patient with no relative or support person present;
  • Homeless patient;
  • Patient with known severe psychiatric illness such as chronic hallucinatory psychosis or paranoid syndrome;
  • Patient participating in or being excluded from another clinical trial;
  • Patient not covered by a social security scheme.

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

208 participants in 2 patient groups

Immersive sensory projections
Experimental group
Description:
Patients will benefit from an immersive sensory environment in the hospital room. This IHP immersive sensory environment consists of the following elements: * light frescoes on the theme of nature, of the canopy type, diffused by a generative circadian cycle. * a soundtrack made up of nature sounds and sounds of life outside the hospital, broadcast in an immersive (moving sounds in the room), random (non-repetitive sounds over time) and generative way. * essential oils
Treatment:
Procedure: Hospitalization in intensive care or continuing care unit
No immersive sensory projections
Active Comparator group
Description:
Standard (control) group: Patients will not have any Immersion Health Project-type immersive sensory projection in the hospital room.
Treatment:
Procedure: Hospitalization in intensive care or continuing care unit

Trial contacts and locations

1

Loading...

Central trial contact

Igor LACOMBAT, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems